WO2023063819A1 - Traitement d'infections parasitaires de poissons - Google Patents
Traitement d'infections parasitaires de poissons Download PDFInfo
- Publication number
- WO2023063819A1 WO2023063819A1 PCT/NL2022/050578 NL2022050578W WO2023063819A1 WO 2023063819 A1 WO2023063819 A1 WO 2023063819A1 NL 2022050578 W NL2022050578 W NL 2022050578W WO 2023063819 A1 WO2023063819 A1 WO 2023063819A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lipopeptide
- scuticociliatosis
- treatment
- fish
- biosurfactant
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title claims abstract description 44
- 241000251468 Actinopterygii Species 0.000 title claims description 38
- 208000030852 Parasitic disease Diseases 0.000 title description 3
- 108010028921 Lipopeptides Proteins 0.000 claims abstract description 97
- 239000003876 biosurfactant Substances 0.000 claims abstract description 81
- 241000782899 Philasterides dicentrarchi Species 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 25
- 230000001580 bacterial effect Effects 0.000 claims description 20
- 241000589774 Pseudomonas sp. Species 0.000 claims description 19
- 239000004094 surface-active agent Substances 0.000 claims description 19
- QYEWAEAWMXRMHB-YFTUCIGFSA-N (4r)-5-[[(3s,6r,9s,12r,15s,18r,21r,22r)-3-[(2s)-butan-2-yl]-6,12-bis(hydroxymethyl)-22-methyl-9,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-18-propan-2-yl-1-oxa-4,7,10,13,16,19-hexazacyclodocos-21-yl]amino]-4-[[(2s)-2-[[(3r)-3-hydroxydecanoyl]amino] Chemical compound CCCCCCC[C@@H](O)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]1[C@@H](C)OC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C(C)C)NC1=O QYEWAEAWMXRMHB-YFTUCIGFSA-N 0.000 claims description 15
- 229930186976 Massetolide Natural products 0.000 claims description 13
- 208000015181 infectious disease Diseases 0.000 claims description 13
- 241000894006 Bacteria Species 0.000 claims description 11
- QYEWAEAWMXRMHB-UHFFFAOYSA-N 8-Angeloyl-8alpha-4,9-Muuroladiene-1,8-diol Natural products CCCCCCCC(O)CC(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC1C(C)OC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC1=O QYEWAEAWMXRMHB-UHFFFAOYSA-N 0.000 claims description 7
- 108010067142 viscosin Proteins 0.000 claims description 7
- 235000019688 fish Nutrition 0.000 description 40
- 241000157468 Reinhardtius hippoglossoides Species 0.000 description 23
- 241000223782 Ciliophora Species 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 241000723298 Dicentrarchus labrax Species 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 241000269908 Platichthys flesus Species 0.000 description 10
- 241000589516 Pseudomonas Species 0.000 description 10
- 244000045947 parasite Species 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 241000269979 Paralichthys olivaceus Species 0.000 description 7
- 241001490743 Scuticociliatia Species 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000251730 Chondrichthyes Species 0.000 description 5
- 241000802092 Paralichthys adspersus Species 0.000 description 5
- 230000002141 anti-parasite Effects 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 239000013535 sea water Substances 0.000 description 5
- 231100000111 LD50 Toxicity 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 3
- 241000972773 Aulopiformes Species 0.000 description 3
- 101000831205 Danio rerio Dynein axonemal assembly factor 11 Proteins 0.000 description 3
- 102100024282 Dynein axonemal assembly factor 11 Human genes 0.000 description 3
- 241001559542 Hippocampus hippocampus Species 0.000 description 3
- 101000831210 Homo sapiens Dynein axonemal assembly factor 11 Proteins 0.000 description 3
- 241000589540 Pseudomonas fluorescens Species 0.000 description 3
- 241000589776 Pseudomonas putida Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000842 anti-protozoal effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 231100000673 dose–response relationship Toxicity 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012909 foetal bovine serum Substances 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000019515 salmon Nutrition 0.000 description 3
- 235000015170 shellfish Nutrition 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- DSYOCLWRCTWQOY-VESOLIDLSA-N (4R)-5-[[(3S,6R,9S,12R,15S,18R,21R,22R)-6,12-bis(hydroxymethyl)-22-methyl-3,9,15-tris(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-18-propan-2-yl-1-oxa-4,7,10,13,16,19-hexazacyclodocos-21-yl]amino]-4-[[(2S)-2-[[(3R)-3-hydroxydecanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoic acid Chemical compound O=C(N[C@@H](C(=O)N[C@@H]1[C@@H](C)OC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C(C)C)NC1=O)CCC(=O)O)[C@@H](NC(=O)C[C@H](O)CCCCCCC)CC(C)C DSYOCLWRCTWQOY-VESOLIDLSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000238424 Crustacea Species 0.000 description 2
- 102000005927 Cysteine Proteases Human genes 0.000 description 2
- 108010005843 Cysteine Proteases Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000007760 Iscove's Modified Dulbecco's Medium Substances 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 241001036089 Pseudomonas fluorescens SS101 Species 0.000 description 2
- 241000233667 Saprolegnia Species 0.000 description 2
- 241000172147 Saprolegnia diclina Species 0.000 description 2
- 241000512310 Scophthalmus maximus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241001247203 Syngnathidae Species 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 241001467393 Vannella sp. Species 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000002543 antimycotic Substances 0.000 description 2
- 239000003096 antiparasitic agent Substances 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000011284 combination treatment Methods 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 208000010824 fish disease Diseases 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- AEDDIBAIWPIIBD-ZJKJAXBQSA-N mangiferin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC=2C(=CC(O)=C(O)C=2)C2=O)C2=C1O AEDDIBAIWPIIBD-ZJKJAXBQSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- 229930014124 (-)-epigallocatechin gallate Natural products 0.000 description 1
- JAYJEXYYCNLGOQ-SXIBJIISSA-N (4r)-5-[[(3s,6r,9s,12r,15s,18r,21r,22r)-3,18-bis[(2r)-butan-2-yl]-6,12-bis(hydroxymethyl)-22-methyl-9,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1-oxa-4,7,10,13,16,19-hexazacyclodocos-21-yl]amino]-4-[[(2s)-2-[[(3s)-3-hydroxydecanoyl]amino]-4-methyl Chemical compound CCCCCCC[C@H](O)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]1[C@@H](C)OC(=O)[C@H]([C@H](C)CC)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([C@H](C)CC)NC1=O JAYJEXYYCNLGOQ-SXIBJIISSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- OXBVVUPTVONEJO-UHFFFAOYSA-N 5-[[3-butan-2-yl-6,12-bis(hydroxymethyl)-22-methyl-9,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-18-propan-2-yl-1-oxa-4,7,10,13,16,19-hexazacyclodocos-21-yl]amino]-4-[[2-(3-hydroxydodecanoylamino)-4-methylpentanoyl]amino]-5-oxopentanoic acid Chemical compound CCCCCCCCCC(O)CC(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC1C(C)OC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC1=O OXBVVUPTVONEJO-UHFFFAOYSA-N 0.000 description 1
- GUMIALLQHODSIG-UHFFFAOYSA-N 5-[[6,12-bis(hydroxymethyl)-22-methyl-9,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-3,18-di(propan-2-yl)-1-oxa-4,7,10,13,16,19-hexazacyclodocos-21-yl]amino]-4-[[2-(3-hydroxydecanoylamino)-4-methylpentanoyl]amino]-5-oxopentanoic acid Chemical compound CCCCCCCC(O)CC(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC1C(C)OC(=O)C(C(C)C)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC1=O GUMIALLQHODSIG-UHFFFAOYSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- AFWTZXXDGQBIKW-UHFFFAOYSA-N C14 surfactin Natural products CCCCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 AFWTZXXDGQBIKW-UHFFFAOYSA-N 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- 108010013198 Daptomycin Proteins 0.000 description 1
- 108020005199 Dehydrogenases Proteins 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000248482 Ichthyophthirius multifiliis Species 0.000 description 1
- 235000013628 Lantana involucrata Nutrition 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- YWQSXCGKJDUYTL-UHFFFAOYSA-N Mangiferin Natural products CC(CCC=C(C)C)C1CC(C)C2C3CCC4C(C)(C)CCCC45CC35CCC12C YWQSXCGKJDUYTL-UHFFFAOYSA-N 0.000 description 1
- JAYJEXYYCNLGOQ-KCABBJLQSA-N Massetolide A Natural products O=C(N[C@@H](C(=O)N[C@@H]1[C@@H](C)OC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([C@H](CC)C)NC1=O)CCC(=O)O)[C@@H](NC(=O)C[C@H](O)CCCCCCC)CC(C)C JAYJEXYYCNLGOQ-KCABBJLQSA-N 0.000 description 1
- DTEBAJZTWHMPEF-KMIBTTNJSA-N Massetolide B Natural products O=C(N[C@@H](C(=O)N[C@@H]1[C@@H](C)OC(=O)[C@@H]([C@H](CC)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([C@H](CC)C)NC1=O)CCC(=O)O)[C@@H](NC(=O)C[C@H](O)CCCCCCCC)CC(C)C DTEBAJZTWHMPEF-KMIBTTNJSA-N 0.000 description 1
- QLBHHKHBJWIIDN-MCHNLAAMSA-N Massetolide C Natural products O=C(N[C@@H](C(=O)N[C@@H]1[C@@H](C)OC(=O)[C@@H]([C@H](CC)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@H](CC)C)NC1=O)CCC(=O)O)[C@@H](NC(=O)C[C@H](O)CCCCCCCCC)CC(C)C QLBHHKHBJWIIDN-MCHNLAAMSA-N 0.000 description 1
- IFZPMYRVFZFPEF-WOGGFMJISA-N Massetolide D Natural products O=C(N[C@@H](C(=O)N[C@@H]1[C@@H](C)OC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@H](CC)C)NC1=O)CCC(=O)O)[C@@H](NC(=O)C[C@H](O)CCCCCCC)CC(C)C IFZPMYRVFZFPEF-WOGGFMJISA-N 0.000 description 1
- GUMIALLQHODSIG-UMJABWICSA-N Massetolide E Natural products O=C(N[C@@H](C(=O)N[C@@H]1[C@@H](C)OC(=O)[C@@H](C(C)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C(C)C)NC1=O)CCC(=O)O)[C@@H](NC(=O)C[C@H](O)CCCCCCC)CC(C)C GUMIALLQHODSIG-UMJABWICSA-N 0.000 description 1
- MVGLWACDWUAYTI-FHAPNJEZSA-N Massetolide G Natural products O=C(N[C@@H](C(=O)N[C@@H]1[C@@H](C)OC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C(C)C)NC1=O)CCC(=O)O)[C@@H](NC(=O)C[C@H](O)CCCCCCCC)CC(C)C MVGLWACDWUAYTI-FHAPNJEZSA-N 0.000 description 1
- DQUZAADVFQDHKJ-GTBDWYEMSA-N Massetolide H Natural products O=C(N[C@@H](C(=O)N[C@@H]1[C@@H](C)OC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C(C)C)NC1=O)CCC(=O)O)[C@@H](NC(=O)C[C@H](O)CCCCCCCCC)CC(C)C DQUZAADVFQDHKJ-GTBDWYEMSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000497908 Miamiensis avidus Species 0.000 description 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
- 206010027982 Morphoea Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000277334 Oncorhynchus Species 0.000 description 1
- 241001327682 Oncorhynchus mykiss irideus Species 0.000 description 1
- 240000007673 Origanum vulgare Species 0.000 description 1
- 241000269978 Pleuronectiformes Species 0.000 description 1
- 241001607433 Pseudomonas fluorescens SBW25 Species 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- JLPULHDHAOZNQI-JLOPVYAASA-N [(2r)-3-hexadecanoyloxy-2-[(9e,12e)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC JLPULHDHAOZNQI-JLOPVYAASA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003904 antiprotozoal agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 229960003168 bronopol Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- DOAKLVKFURWEDJ-QCMAZARJSA-N daptomycin Chemical compound C([C@H]1C(=O)O[C@H](C)[C@@H](C(NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@H](C(=O)N1)[C@H](C)CC(O)=O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)CCCCCCCCC)C(=O)C1=CC=CC=C1N DOAKLVKFURWEDJ-QCMAZARJSA-N 0.000 description 1
- 229960005484 daptomycin Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 150000002632 lipids Chemical group 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229940043357 mangiferin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000009343 monoculture Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- NJGWOFRZMQRKHT-UHFFFAOYSA-N surfactin Natural products CC(C)CCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-UHFFFAOYSA-N 0.000 description 1
- NJGWOFRZMQRKHT-WGVNQGGSSA-N surfactin C Chemical compound CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-WGVNQGGSSA-N 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 108010052945 thanamycin Proteins 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P15/00—Biocides for specific purposes not provided for in groups A01P1/00 - A01P13/00
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Definitions
- P. dicentrarchi may enter fish farms continuously through the feeder channels and they increase in number in fish tanks as the temperature and organic matter levels rise, conditions that increase the risk of fish suffering from scuticociliatosis.
- Lama R et al. "Turbot (Scophthalmus maximus) Nk-lysin induces protection against the pathogenic parasite Philasterides dicentrarchi via membrane disruption", Fish & Shellfish Immunology, 2018, describes that Turbot Nk-lysin has the ability to inhibit proliferation of the Philasterides dicentrarchi parasite.
- W02019101739A1 describes the use of lipopeptide biosurfactants for use in the treatment of white spot disease in fresh water and marine fish.
- the invention further applies to a device, apparatus, or system comprising one or more of the characterizing features described in the description and/or shown in the attached drawings.
- the invention further pertains to a method or process comprising one or more of the characterizing features described in the description and/or shown in the attached drawings.
- PS Pseudomonas H6 biosurfactant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Environmental Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Agronomy & Crop Science (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Dentistry (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
L'invention concerne un biotensioactif lipopeptidique destiné à être utilisé dans le traitement de la scuticociliatose chez un organisme marin sensible à la scuticociliatose.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL2029375A NL2029375B1 (en) | 2021-10-11 | 2021-10-11 | Treatment of parasitic infections of fish |
NL2029375 | 2021-10-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023063819A1 true WO2023063819A1 (fr) | 2023-04-20 |
Family
ID=80113372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL2022/050578 WO2023063819A1 (fr) | 2021-10-11 | 2022-10-10 | Traitement d'infections parasitaires de poissons |
Country Status (2)
Country | Link |
---|---|
NL (1) | NL2029375B1 (fr) |
WO (1) | WO2023063819A1 (fr) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019101739A1 (fr) | 2017-11-21 | 2019-05-31 | Nederlands Instituut Voor Ecologie (Nioo-Knaw) | Traitement d'infections parasitaires touchant les surfaces des poissons |
-
2021
- 2021-10-11 NL NL2029375A patent/NL2029375B1/en active
-
2022
- 2022-10-10 WO PCT/NL2022/050578 patent/WO2023063819A1/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019101739A1 (fr) | 2017-11-21 | 2019-05-31 | Nederlands Instituut Voor Ecologie (Nioo-Knaw) | Traitement d'infections parasitaires touchant les surfaces des poissons |
Non-Patent Citations (19)
Title |
---|
AL-JUBURY A ET AL.: "Impact of Pseudomonas H6 surfactant on all external life cycle stages of the fish parasitic ciliate Ichthyophthirius multifiliis", JOURNAL OF FISH DISEASES, 2018 |
AL-JUBURY A ET AL: "Impact of Pseudomonas H6 surfactant on all external life cycle stages of the fish parasitic ciliate Ichthyophthirius multifiliis", vol. 41, no. 7, 19 April 2018 (2018-04-19), GB, pages 1147 - 1152, XP055916594, ISSN: 0140-7775, Retrieved from the Internet <URL:https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjfd.12810> DOI: 10.1111/jfd.12810 * |
DE BRUIJN IDE KOCK MJDYANG MDE WAARD PVAN BEEK TARAAIJMAKERS JM: "Genome-based discovery, structure prediction and functional analysis of cyclic lipopeptide antibiotics in Pseudomonas species", MOLECULAR MICROBIOLOGY, vol. 63, no. 2, 2007, pages 417 - 28 |
DENIZOT, F.LANG, R: "Rapid colorimetric assay for cell growth and survival", J. IMMUNOL. METHODS, vol. 89, 1986, pages 271 - 277, XP023891676, DOI: 10.1016/0022-1759(86)90368-6 |
IGLESIAS, R.PARAMA, A.ALVAREZ, M. F.LEIRO, J.AJA, C.SANMARTIN, M.L.: "vitro growth requeriments for the fish pathogen Philasterides dicentrarchi (Ciliophora, Scuticociliatida", VET. PARASITOL., vol. 111, 2003, pages 19 - 30, XP055916596, DOI: 10.1016/S0304-4017(02)00350-3 |
IGLESIAS, R.PARAMA, A.ALVAREZ, M. F.LEIRO, J.FERNANDEZ, J.SANMARTIN, M.L.: "Philasterides dicentrarchi (Ciliophora, Scuticociliatida) as the causative agent of scuticociliatosis in farmed turbot, Scophthalmus maximus in Galicia (NW Spain", DIS. AQUAT. ORGAN., vol. 46, 2001, pages 47 - 55 |
IGLESIAS, R.PARAMA, A.ALVAREZ, M.F.LEIRO, J.SANMARTIN, M.L.: "Antiprotozoals effective in vitro against the scuticociliate fish pathogen Philasterides dicentrarchi", DIS. AQUAT. ORGAN., vol. 49, 2002, pages 191 - 19 |
JENSEN HANNAH MALENE ET AL.: "Gilt amoebae from freshwater rainbow trout (Oncorhynchus mykiss): In vitro evaluation of antiparasitic compounds against Vannella sp", JOURNAL OF FISH DISEASES, 2020 |
JENSEN HANNAH MALENE ET AL: "Gill amoebae from freshwater rainbow trout ( Oncorhynchus mykiss ): In vitro evaluation of antiparasitic compounds against Vannella sp.", vol. 43, no. 6, 15 April 2020 (2020-04-15), GB, pages 665 - 672, XP055916595, ISSN: 0140-7775, Retrieved from the Internet <URL:https://onlinelibrary.wiley.com/doi/full-xml/10.1111/jfd.13162> DOI: 10.1111/jfd.13162 * |
LAMA R ET AL.: "Turbot (Scophthalmus maximus) Nk-lysin induces protection against the pathogenic parasite Philasterides dicentrarchi via membrane disruption", FISH & SHELLFISH IMMUNOLOGY, 2018 |
LAMA R ET AL: "Turbot (Scophthalmus maximus) Nk-lysin induces protection against the pathogenic parasitePhilasterides dicentrarchivia membrane disruption", FISH & SHELLFISH IMMUNOLOGY, ACADEMIC PRESS, LONDON, GB, vol. 82, 4 August 2018 (2018-08-04), pages 190 - 199, XP085487408, ISSN: 1050-4648, DOI: 10.1016/J.FSI.2018.08.004 * |
LEIRO, J.ARRANZ, J.A.PARAMA, A.ALVAREZ, M.F.SANMARTIN, M.L.: "In vitro effects of the polyphenols resveratrol, mangiferin and epigallocatechin-3-gallate on the scuticociliate fish pathogen Philasterides dicentrarchi", DIS. AQUAT. ORGAN., vol. 59, no. 2, 2004, pages 171 - 174 |
LIU, Y.RZESZUTEK, E.VAN DER VOORT, M.WU, C.H.THOEN, E.SKAAR, I.BULONE, V.DORRESTEIN, P.C.RAAIJMAKERS JM.DE BRUIJN I: "Diversity of Aquatic Pseudomonas Species and Their Activity against the Fish Pathogenic Oomycete Saprolegnia", PLOS ONE, vol. 10, no. 8, 2015, pages e0136241, XP055451134, DOI: 10.1371/journal.pone.0136241 |
PARAMA ET AL.: "Scuticociliate cysteine proteinases modulate turbot leucocyte functions", FISH & SHELLFISH IMMUNOLOGY, 2007 |
PARAMA ET AL: "Scuticociliate cysteine proteinases modulate turbot leucocyte functions", FISH & SHELLFISH IMMUNOLOGY, ACADEMIC PRESS, LONDON, GB, vol. 23, no. 5, 10 September 2007 (2007-09-10), pages 945 - 956, XP022240666, ISSN: 1050-4648, DOI: 10.1016/J.FSI.2007.02.001 * |
PARK SEONG BIN ET AL.: "Combination treatment against scuticociliatosis by reducing the inhibitor effect of mucus in olive flounder, Paralichthys olivaceus", FISH & SHELLFISH IMMUNOLOGY, 2014 |
PARK SEONG BIN ET AL: "Combination treatment against scuticociliatosis by reducing the inhibitor effect of mucus in olive flounder, Paralichthys olivaceus", FISH & SHELLFISH IMMUNOLOGY, vol. 38, no. 2, 1 June 2014 (2014-06-01), GB, pages 282 - 286, XP055916574, ISSN: 1050-4648, DOI: 10.1016/j.fsi.2014.03.023 * |
YIYING LIU ET AL.: "Diversity of Aquatic Pseudomonas Species and Their Activity against the Fish Pathogenic Oomycete Saprolegnia", PLOS ONE, 2015 |
YIYING LIU ET AL: "Diversity of Aquatic Pseudomonas Species and Their Activity against the Fish Pathogenic Oomycete Saprolegnia", PLOS ONE, vol. 10, no. 8, 28 October 2015 (2015-10-28), pages e0136241, XP055451134, DOI: 10.1371/journal.pone.0136241 * |
Also Published As
Publication number | Publication date |
---|---|
NL2029375B1 (en) | 2023-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kewcharoen et al. | Probiotic effects of Bacillus spp. from Pacific white shrimp (Litopenaeus vannamei) on water quality and shrimp growth, immune responses, and resistance to Vibrio parahaemolyticus (AHPND strains) | |
Langworthy et al. | Macrofilaricidal activity of tetracycline against the filarial nematode Onchocerca ochengi: elimination of Wolbachia precedes worm death and suggests a dependent relationship | |
Karim et al. | Probiotic strains for shellfish aquaculture: protection of eastern oyster, Crassostrea virginica, larvae and juveniles againsl bacterial challenge | |
Balicka-Ramisz et al. | Occurrence of coccidia infection in pigeons in amateur husbandry. Diagnosis and prevention | |
US20230107426A1 (en) | Treatment of Parasitic Infections of Fish Surfaces | |
Tamamdusturi et al. | Administration of microencapsulated probiotic Bacillus sp. NP5 and prebiotic mannan oligosaccharide for prevention of Aeromonas hydrophila infection on Pangasianodon hypophthalmus | |
Chukanhom et al. | Freshwater fungi isolated from eggs of the common carp (Cyprinus carpio) in Thailand | |
Morales-Covarrubias et al. | Evaluation of medicinal plants and colloidal silver efficiency against Vibrio parahaemolyticus infection in Litopenaeus vannamei cultured at low salinity | |
Shoemaker et al. | Overview of fish immune system and infectious diseases | |
Balachandran et al. | A study on the effect of using mangrove leaf extracts as a feed additive in the progress of bacterial infections in marine ornamental fish | |
Korkut et al. | The effect of temperature on bacteria-host interactions in the freshwater crayfish, Pacifastacus leniusculus | |
Alishahi et al. | Effect of dietary chitosan on immune response and disease resistance in Cyprinus carpio. | |
Friedman et al. | Development of an oral administration of oxytetracycline to control losses due to withering syndrome in cultured red abalone Haliotis rufescens | |
Salem et al. | Incidence of gastrointestinal parasites in pigeons with an assessment of the nematocidal activity of chitosan nanoparticles against Ascaridia columbae | |
US10987393B2 (en) | Method for preventing and controlling bacterial infections in salmonid fish using Quillaja saponaria extracts | |
NL2029375B1 (en) | Treatment of parasitic infections of fish | |
Sriwulan et al. | Screening and application of lactic acid bacteria isolated from vanamei shrimp (Litopenaeus vannamei) intestine as a probiotic potential for tiger shrimp (Penaeus monodon). | |
Adel et al. | Antimicrobial activity and enzymes on skin mucus from male and female Caspian kutum (Rutilus frisii kutum Kamensky, 1901) specimens | |
SA Salama et al. | The impact of co-infection of sea lice and its concurrent some bacterial diseases with field treatment trials in some marine cultured fishes | |
Park et al. | Combination treatment against scuticociliatosis by reducing the inhibitor effect of mucus in olive flounder, Paralichthys olivaceus | |
KR101793393B1 (ko) | 알렉산드리움 속 와편모류를 포함하는 스쿠티카충 억제제 | |
Ramesh et al. | Feasibility of shrimp gut probionts with anti-vibrio and anti-QS in penaeid culture | |
Borisutpeth et al. | The in vitro antifungal effects of chlorine dioxide on water molds | |
Parmar et al. | Efficacy of closantel against benzimidazole resistant Haemonchus contortus infection in sheep | |
Muthee | Anthelmintic efficacy and safety of selected medicinal plants against mixed gastrointestinal nematodes in artificially infected sheep |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22789709 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22789709 Country of ref document: EP Kind code of ref document: A1 |